Status:
UNKNOWN
Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block
Lead Sponsor:
Assiut University
Conditions:
Hip Fractures
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. * Our primary outcome of the...
Eligibility Criteria
Inclusion
- • Patients aged 18 years or more.
- Patients with American society of anesthesiologists (ASA) classification class I or II
- Patients weight range from 50 to 90 Kgs
Exclusion
- • Patient refusal of peripheral nerve block
- Patient with infection at the site of injection
- Patient with coagulopathy
- Patients with known allergy to used medications.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06180031
Start Date
January 1 2024
End Date
March 30 2025
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt, 71515